SYBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stock Yards Bancorp Inc (SYBT) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants a clear entry. The stock is near key support but the technical trend is still weak, with bearish MACD momentum and no confirmed buy signal from Intellectia’s proprietary tools. Analyst sentiment is mixed-to-neutral with modestly rising price targets, insider buying is a positive, but the options market is heavily put-skewed. My direct view: hold and wait rather than buy now.
SYBT is trading at 69.31, below the pivot level of 71.411 and just above S1 at 69.543, indicating it is sitting near support but not showing strength. The MACD histogram is -0.477 and negatively expanding, which points to bearish momentum. RSI_6 at 28.733 suggests the stock is oversold/near oversold, but moving averages are only converging rather than turning up, so there is no confirmed reversal yet. The short-term pattern data implies only modest upside over the next month, not a strong immediate trend.
Insiders are buying aggressively, with buying up 1802.22% over the last month, which is the strongest positive signal in the dataset. Analysts have been steadily raising price targets, including Piper Sandler to $78, Stephens to $70, and Keefe Bruyette to $81, showing improving valuation expectations. Hovde also upgraded the stock to Outperform in March. The stock pattern data suggests a possible 3.28% gain over the next month, which supports a mild rebound case.
There is no recent news catalyst, so no near-term event-driven upside is visible. Technical momentum is negative, with a falling MACD histogram and price below the pivot. Options positioning is heavily put-skewed, which signals caution. Hedge funds are neutral with no significant recent trading trend, and there is no congress trading data to support a political catalyst. Analyst ratings are still mostly Neutral/Market Perform/Equal Weight, so Wall Street remains unconvinced of major upside.
No quarterly financial snapshot was available because of a data error, so there is no reliable latest-quarter revenue, earnings, or margin breakdown to assess. Because the latest quarter season is not provided, I cannot confirm quarter-over-quarter growth trends from the supplied data.
Analyst sentiment is cautiously constructive but not bullish. Price targets have inched higher recently: Piper Sandler raised its target to $78 and kept Neutral, Stephens moved to $70 and kept Equal Weight, and Keefe Bruyette lifted targets to $80-$81 while maintaining Market Perform. Hovde upgraded the stock to Outperform with a $75 target. The Wall Street pro side is that estimates are drifting up and insider buying is strong; the con side is that most ratings remain neutral and price targets cluster close to the current price, limiting obvious upside.
